Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Acquisitions & DivestmentsChange in CashChange in InventoryDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Codexis (CDXS) Gains from Investment Securities (2016 - 2024)

Historic Gains from Investment Securities for Codexis (CDXS) over the last 14 years, with Q4 2024 value amounting to $3.0 million.

  • Codexis' Gains from Investment Securities fell 6401.68% to $3.0 million in Q4 2024 from the same period last year, while for Mar 2025 it was $6.9 million, marking a year-over-year decrease of 4379.5%. This contributed to the annual value of $6.9 million for FY2024, which is 4349.57% down from last year.
  • As of Q4 2024, Codexis' Gains from Investment Securities stood at $3.0 million, which was down 6401.68% from $3.9 million recorded in Q3 2024.
  • In the past 5 years, Codexis' Gains from Investment Securities ranged from a high of $8.3 million in Q4 2023 and a low of -$17000.0 during Q2 2024
  • For the 5-year period, Codexis' Gains from Investment Securities averaged around $2.3 million, with its median value being $1.0 million (2020).
  • As far as peak fluctuations go, Codexis' Gains from Investment Securities skyrocketed by 286036.87% in 2021, and later plummeted by 9773.33% in 2024.
  • Over the past 5 years, Codexis' Gains from Investment Securities (Quarter) stood at $743000.0 in 2020, then skyrocketed by 764.6% to $6.4 million in 2021, then crashed by 95.33% to $300000.0 in 2022, then surged by 2671.67% to $8.3 million in 2023, then crashed by 64.02% to $3.0 million in 2024.
  • Its Gains from Investment Securities was $3.0 million in Q4 2024, compared to $3.9 million in Q3 2024 and -$17000.0 in Q2 2024.